Brain imaging benchmark could better classify Alzheimer's disease-related changes

Why do some patients with precursors to bone marrow cancer never develop the disease? Researchers from the Department of Forensic Medicine at Aarhus University have discovered that some cells enter a dormant state and create a defense against cancer—a breakthrough that could lead to early treatment.

The World Health Organization insisted Friday that there was no evidence of any harm from an important vaccine ingredient, which a US medical panel voted to oppose this week.

Mount Sinai researchers have published the first study to use wearable devices to assess how inflammation and symptoms in inflammatory bowel disease (IBD) affect sleep characteristics and sleep patterns over time.

Imagine getting an MRI of your knees and being told you have "mild intrasubstance degeneration of the posterior horn of the medial meniscus."

Proposed measures to impose historic cuts on Medicaid spending could have a devastating impact on millions of older working-age Americans, according to a new analysis conducted by Nari Rhee, director of the Labor Center's Retirement Security Program, and issued by the UC Berkeley Labor Center.

Placing physically and sexually aggressive older psychiatric patients in general hospital wards is both unsafe and unethical, a University of Otago—Ōtākou Whakaihu Waka-led paper argues.

A systematic review from King's College London sets out to explore the geographic barriers to dental care and makes dental access recommendations for health policy.

Scientists have refined a new way of using genetics to identify whether someone has type 1 or type 2 diabetes in Chinese populations—and it is now being used in a large clinical trial to improve treatment in the region.

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in-depth studies into the biology of blood to better understand the aging process and why some people become more susceptible to disease over the years.

Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why they are connected remains unknown. Researchers from Mass General Brigham discovered that HBV does not cause liver inflammation or cancer on its own, but worsens liver inflammation and may make patients more susceptible to early cancer development caused by environmental carcinogens. Limiting carcinogen exposure or reducing inflammation could mitigate this risk. The results are published in Nature Communications.

As sport-related concussions continue to spark global concern, researchers at the University of South Australia (UniSA) are turning their attention to a largely overlooked group—non-professional athletes—calling for more rigorous return-to-play assessments to protect everyday players.

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications, such as cirrhosis and liver cancer, making it crucial to detect early and initiate treatment.

The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.

A new study by UCLA researchers shows that removing a modest $45 out-of-pocket fee significantly improved access to digital breast tomosynthesis (3D mammography), an advanced breast cancer screening technology. Researchers found that eliminating the fee increased overall usage by several percentage points and particularly benefited underserved patient populations, including racial and ethnic minorities and non-English speakers. The study appears in the Journal of the American College of Radiology.

Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors when they are treated with the immune-suppressing drug cyclophosphamide. Survival rates at one year were on par with rates seen in other studies with fully matched donors.

A new update, led by researchers at the UNC School of Medicine and the Gillings School of Global Public Health, describes major findings from the past half decade in the realm of psychiatric genomics and next steps for researchers.

Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize dysfunctional or "exhausted" immune cells in their fight against cancer.

A simple saliva test could transform the lives of millions of children and adults worldwide who are on the keto diet to manage their epilepsy, and who currently endure uncomfortable finger prick tests.